Single studies assessed the potential role of other novel biomarkers including TFF-3, GST, OPN, MCP-1, and TLR4 [70,131,146]; however, due to the lack of data, further evaluation of their utility in differential diagnosis of acute renal dysfunction among patients with cirrhosis. The gene discussed is CCL2; the disease is Cirrhosis.